Cargando…
Prostaglandins in the pathogenesis of kidney diseases
Prostaglandins (PGs) are important lipid mediators produced from arachidonic acid via the sequential catalyzation of cyclooxygenases (COXs) and specific prostaglandin synthases. There are five subtypes of PGs, namely PGE2, PGI2, PGD2, PGF2α, and thromboxane A2 (TXA2). PGs exert distinct roles by com...
Autores principales: | Li, Yuanyuan, Xia, Weiwei, Zhao, Fei, Wen, Zhaoying, Zhang, Aihua, Huang, Songming, Jia, Zhanjun, Zhang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995175/ https://www.ncbi.nlm.nih.gov/pubmed/29899878 http://dx.doi.org/10.18632/oncotarget.25005 |
Ejemplares similares
-
Role of COX-2/mPGES-1/Prostaglandin E2 Cascade in Kidney Injury
por: Jia, Zhanjun, et al.
Publicado: (2015) -
MnTBAP therapy attenuates the downregulation of sodium transporters in obstructive kidney disease
por: Liu, Mi, et al.
Publicado: (2017) -
Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation
por: Xia, Weiwei, et al.
Publicado: (2021) -
Gasdermin E Deletion Attenuates Ureteral Obstruction- and 5/6 Nephrectomy-Induced Renal Fibrosis and Kidney Dysfunction
por: Wu, Mengying, et al.
Publicado: (2021) -
Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease
por: Zhang, Yue, et al.
Publicado: (2015)